| MQ Walter Scott Glbl EQ Active ETF (Managed Fund) (MQWS) |
Financials |
$26 |
Monthly Redemptions, Applications and Units on Issue
|
6 Feb 2026 9:30AM |
$8.760 |
$8.680 |
fallen by
0.91%
|
|
| Macquarie Core Global Equity (Hedged) Active ETF (MQHG) |
Financials |
$1 |
Monthly Redemptions, Applications and Units on Issue
|
6 Feb 2026 9:30AM |
$10.290 |
$10.160 |
fallen by
1.26%
|
|
| Macquarie Core Global Equity Active ETF (MQEG) |
Financials |
$100 |
Monthly Redemptions, Applications and Units on Issue
|
6 Feb 2026 9:30AM |
$13.010 |
$12.870 |
fallen by
1.08%
|
|
| Macquarie Core Australian Equity Active ETF (MQAE) |
Financials |
$861 |
Monthly Redemptions, Applications and Units on Issue
|
6 Feb 2026 9:30AM |
$12.110 |
$11.840 |
fallen by
2.23%
|
|
| Terragen Holdings Limited (TGH) ORDINARY FULLY PAID |
Materials |
$13 |
Proposed issue of securities - TGH
|
6 Feb 2026 9:30AM |
$0.021 |
$0.025 |
risen by
19.05%
|
|
| Terragen Holdings Limited (TGH) ORDINARY FULLY PAID |
Materials |
$13 |
Proposed issue of securities - TGH
|
6 Feb 2026 9:30AM |
$0.021 |
$0.025 |
risen by
19.05%
|
|
| Terragen Holdings Limited (TGH) ORDINARY FULLY PAID |
Materials |
$13 |
Terragen Raises $7.0m to Accelerate Global Commercialisation
|
6 Feb 2026 9:29AM |
$0.021 |
$0.025 |
risen by
19.05%
|
|
TGH - Price-sensitive ASX Announcement
Full Release
Key Points
- Terragen completed an A$7.0 million equity raising.
- The equity raising includes Institutional and Conditional Placements.
- Proceeds will fund R&D and global commercialisation efforts.
- Terragen aims to expand manufacturing and distribution partnerships.
- Dr. Michele Allan AO appointed as Chair, replacing Mr. Michael Barry.
- The initiative supports Terragen’s strategy for sustainable growth in agriculture.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ariana Resources Plc (AA2) CHESS DEPOSITARY INTERESTS 1:10 |
Materials |
$18 |
Cleansing Notice
|
6 Feb 2026 9:29AM |
$0.350 |
$0.350 |
fallen by
0%
|
|
| Macquarie Global Yield Maximiser Active ETF (MQYM) |
Financials |
$26 |
Monthly Redemptions, Applications, Units on Issue and OTC
|
6 Feb 2026 9:29AM |
$50.280 |
$50.150 |
fallen by
0.26%
|
|
| Macquarie Dynamic Bond Active ETF (Managed Fund) (MQDB) |
Financials |
$100 |
Monthly Redemptions, Applications, Units on Issue and OTC
|
6 Feb 2026 9:29AM |
$10.740 |
$10.800 |
risen by
0.56%
|
|
| Macquarie Subordinated Debt Active ETF (MQSD) |
Financials |
$374 |
Monthly Redemptions, Applications, Units on Issue and OTC
|
6 Feb 2026 9:29AM |
$50.450 |
$50.450 |
fallen by
0%
|
|
| Macquarie Income Opp Active ETF (Managed Fund) (MQIO) |
Financials |
$91 |
Monthly Redemptions, Applications, Units on Issue and OTC
|
6 Feb 2026 9:29AM |
$10.640 |
$10.660 |
risen by
0.19%
|
|
| Iondrive Limited (ION) ORDINARY FULLY PAID |
Materials |
$45 |
Application for quotation of securities - ION
|
6 Feb 2026 9:28AM |
$0.040 |
$0.035 |
fallen by
12.50%
|
|
| ARC Funds Limited (ARC) ORDINARY FULLY PAID |
Financials |
$8 |
Application for quotation of securities - ARC
|
6 Feb 2026 9:28AM |
$0.115 |
$0.115 |
fallen by
0%
|
|
| Caprice Resources Limited (CRS) ORDINARY FULLY PAID |
Materials |
$63 |
Appointment of Highly Experienced Exploration Manager
|
6 Feb 2026 9:28AM |
$0.095 |
$0.090 |
fallen by
5.26%
|
|
| Cyprium Metals Limited (CYM) ORDINARY FULLY PAID |
Materials |
$261 |
Entitlement Offer - Offer Booklet and Access Letter
|
6 Feb 2026 9:28AM |
$0.495 |
$0.460 |
fallen by
7.07%
|
|
| Altitude Minerals Ltd (ATT) ORDINARY FULLY PAID |
Materials |
$7 |
Cleansing Notice - Share Issue
|
6 Feb 2026 9:27AM |
$0.023 |
$0.020 |
fallen by
13.04%
|
|
| Rapid Critical Metals Limited (RCM) ORDINARY FULLY PAID |
Materials |
$64 |
Latest Intercepts Confirm Continuity Across Drill Program
|
6 Feb 2026 9:27AM |
$0.069 |
$0.054 |
fallen by
21.74%
|
|
RCM - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade silver mineralisation confirmed across multiple drill sections.
- Results suggest additional sub-parallel mineralised structures in the Webbs system.
- Mineralisation remains open along strike and at depth, indicating exploration potential.
- Drilling supports geological model of stacked or parallel lodes within a broader corridor.
- Future exploration will focus on further delineating the resource with planned follow-up drilling.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| UBS IQ Cash ETF (MONY) |
- |
$100 |
Admission and Commencement of Trading - MONY
|
6 Feb 2026 9:27AM |
$19.990 |
$50.040 |
risen by
150.33%
|
|
| Pursuit Minerals Limited (PUR) ORDINARY FULLY PAID |
Materials |
$18 |
Application for quotation of securities - PUR
|
6 Feb 2026 9:26AM |
$0.110 |
$0.094 |
fallen by
14.55%
|
|
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$100 |
Update - Notification of buy-back - CAMG
|
6 Feb 2026 9:26AM |
$0.700 |
$0.695 |
fallen by
0.71%
|
|
| Flagship Minerals Limited (FLG) ORDINARY FULLY PAID |
Materials |
$66 |
Pantanillo - ASTER Study - Extensive Alteration Footprint
|
6 Feb 2026 9:26AM |
$0.230 |
$0.210 |
fallen by
8.70%
|
|
FLG - Price-sensitive ASX Announcement
Full Release
Key Points
- ASTER study confirms Pantanillo as an epithermal-porphyry system.
- Alteration footprint identified over 40 square kilometers.
- Numerous new exploration targets discovered.
- Strategy includes updating resources to JORC Code (2012) standards.
- Advancing metallurgical tests and conducting extensional drilling by 2026.
- Potential for undiscovered mineralization beneath altered lithocaps.
- Integration of ASTER results with existing datasets for exploration.
- Fieldwork to include alteration mapping and geochemical sampling.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pursuit Minerals Limited (PUR) ORDINARY FULLY PAID |
Materials |
$18 |
Application for quotation of securities - PUR
|
6 Feb 2026 9:26AM |
$0.110 |
$0.094 |
fallen by
14.55%
|
|
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$1,586 |
First patient dosed in Neuren PMS Phase 3 trial
|
6 Feb 2026 9:26AM |
$13.200 |
$12.520 |
fallen by
5.15%
|
|
NEU - Price-sensitive ASX Announcement
Full Release
Key Points
- First Phase 3 trial for Phelan-McDermid syndrome.
- Trial involves drug NNZ-2591.
- Randomized, double-blind, placebo-controlled study.
- Involves 160 children aged 3 to 12 years.
- Has FDA's Fast Track, Rare Pediatric Disease, and Orphan Drug designations.
- Strong community interest with 25 families referred and more on waitlists.
- Two sites activated, 20 more progressing in the US.
- Neuren is the Presenting Sponsor of the 2026 Phelan-McDermid Syndrome Foundation Family Conference.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pursuit Minerals Limited (PUR) ORDINARY FULLY PAID |
Materials |
$18 |
Section 708A Cleansing Notice
|
6 Feb 2026 9:26AM |
$0.110 |
$0.094 |
fallen by
14.55%
|
|
PUR - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of Tranche 1 with 46,947,370 shares issued.
- Raised $4,460,000 at $0.095 per share.
- Section 708A Cleansing Notice issued.
- Compliance with Corporations Act confirmed.
- PAC Partners Securities Pty Ltd acted as Lead Manager.
- Second tranche expected to raise $2,540,000.
- Exercise of 141,465 unlisted options at $0.09.
- Issuance of options to directors and officers planned.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.